The Global Pharmaceutical Omega-3 API Market is entering a sustained expansion cycle, driven by rising prescription demand for cardiovascular-risk reduction therapies and growing reliance on pharmaceutical-grade marine lipid purification. The market is projected to grow from USD 1.1 billion in 2026 to USD 2.3 billion by 2036, registering a CAGR of 7.7% during the forecast period. Unlike...